Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2025

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Presenter: Jeffrey Popma

October 28, 2025

Presentation NY Valves 2024

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Presenter: Azeem Latib

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

Presenter: Charles J. Davidson

June 06, 2024

Presentation NY Valves 2024

TRILUMINATE: Looking Beyond the Headlines – What Lessons Have We Learned?

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

Case Presentation 1: T-TEER With TriClip in a Patient With Atrial Functional TR

Presenter: Matthew J. Price

June 06, 2024

Presentation THT 2024

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Presenter: Scott Solomon

March 04, 2024

Presentation

Rapid Rule Out of Acute MI With Single High-Sensitivity Cardiac Troponin T Below Limit of Detection

April 17, 2017

Presentation TCT 2016

Device Performance in Pre-Approval Studies vs Unrestricted Real-World Use: Lessons Learned and Future Opportunities

Presenter: Owen Faris, Mitchell W. Krucoff

October 31, 2016

Presentation TCT 2016

Key Note Lecture II. Regulatory Reform of Medical Device Approvals by the European Commission Motivating Factors, Anticipated Changes, and Timelines

Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Alan G. Fraser

October 31, 2016

Advertisement

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

TRISCEND II: Understanding the Study Design and Interpreting the Results

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

TRILUMINATE: Looking Beyond the Headlines – What Lessons Have We Learned?

Case Presentation 1: T-TEER With TriClip in a Patient With Atrial Functional TR

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Rapid Rule Out of Acute MI With Single High-Sensitivity Cardiac Troponin T Below Limit of Detection

Device Performance in Pre-Approval Studies vs Unrestricted Real-World Use: Lessons Learned and Future Opportunities

Key Note Lecture II. Regulatory Reform of Medical Device Approvals by the European Commission Motivating Factors, Anticipated Changes, and Timelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content